148 related articles for article (PubMed ID: 10776190)
1. Prostacycline (Flolan). Intravenous nursing responsibilities in the care of the patient with primary pulmonary hypertension.
Benvenuto DB
J Intraven Nurs; 1999; 22(5):267-72. PubMed ID: 10776190
[TBL] [Abstract][Full Text] [Related]
2. Intravenous epoprostenol: a new therapy for primary pulmonary hypertension.
Sabo JA; Nord CP
Crit Care Nurse; 2000 Dec; 20(6):31-40. PubMed ID: 11878257
[No Abstract] [Full Text] [Related]
3. Practical aspects of continuous intravenous treprostinil therapy.
Widlitz AC; McDevitt S; Ward GR; Krichman A
Crit Care Nurse; 2007 Apr; 27(2):41-2, 44-5, 47-50; quiz 51. PubMed ID: 17389412
[No Abstract] [Full Text] [Related]
4. [Education of patients treated with a continuous epoprostenol infusion for pulmonary hypertension].
Marlier D
Soins; 2006 May; (705 Suppl):S7-12. PubMed ID: 16771257
[No Abstract] [Full Text] [Related]
5. Epoprostenol therapy for primary pulmonary hypertension.
Cheever KH; Kitzes B; Genthner D
Crit Care Nurse; 1999 Aug; 19(4):20-7. PubMed ID: 10614244
[TBL] [Abstract][Full Text] [Related]
6. Patient safety challenges in treprostinil therapy.
Roncesvalles A; Lee FW; Camamo J; Priestley G
Medsurg Nurs; 2008 Apr; 17(2):101-6. PubMed ID: 18517170
[TBL] [Abstract][Full Text] [Related]
7. Continuous intravenous prostacyclin for advanced primary pulmonary hypertension.
Archer-Chicko C
Dimens Crit Care Nurs; 2000; 19(2):14-21. PubMed ID: 10876492
[TBL] [Abstract][Full Text] [Related]
8. Treprostinil for pulmonary hypertension.
Vachiéry JL; Naeije R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
[TBL] [Abstract][Full Text] [Related]
9. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
Kato H; Katori T; Nakamura Y; Kawarasaki H
Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
[TBL] [Abstract][Full Text] [Related]
10. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension--beyond vasodilator therapy.
Fishman AP
N Engl J Med; 1998 Jan; 338(5):321-2. PubMed ID: 9445414
[No Abstract] [Full Text] [Related]
13. Use of epoprostenol (Flolan) in the management of primary pulmonary hypertension.
Kayser SR
Prog Cardiovasc Nurs; 1998; 13(3):39-41, 45. PubMed ID: 9950022
[No Abstract] [Full Text] [Related]
14. Advances in prostacyclin therapy for pulmonary arterial hypertension.
Eells PL
Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
[No Abstract] [Full Text] [Related]
15. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
Botney M
N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
[No Abstract] [Full Text] [Related]
16. Treprostinil: new drug. Pulmonary artery hypertension: just another (disappointing) prostacycline analogue.
Prescrire Int; 2006 Oct; 15(85):177-9. PubMed ID: 17128524
[TBL] [Abstract][Full Text] [Related]
17. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions.
Scelsi L; Ghio S; Campana C; D'Armini AM; Serio A; Klersy C; Piovella F; Viganò M; Tavazzi L
Ital Heart J; 2004 Aug; 5(8):618-23. PubMed ID: 15554033
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):170-2. PubMed ID: 17332729
[TBL] [Abstract][Full Text] [Related]
19. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
20. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery.
Bildirici I; Shumway JB
Obstet Gynecol; 2004 May; 103(5 Pt 2):1102-5. PubMed ID: 15121623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
